Clinical Trial: Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07247370) titled 'Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)' on Nov. 16.

Brief Summary: To assess the safety, feasibility and preliminary efficacy of ketamine-enhanced therapy (KET) for alcohol use disorder (AUD) and comorbid major depressive disorder (MDD) in an open-label, single arm, pilot clinical trial.

Study Start Date: Dec. 10

Study Type: INTERVENTIONAL

Condition: Alcohol Use Disorder (AUD) Major Depressive Disorder (MDD) Comorbidities and Coexisting Conditions

Intervention: DRUG: Ketamine

Subcutaneous administration of of Ketamine across 3 dosing sessions (at week 2, 4 ...